Jiangsu (SH:688426) Zheng Quan Shi Bao Wang·2025-03-07 08:20Core Viewpoint - Kangwei Century (688426) announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostic Technology Co., Ltd., has received a Class III Medical Device Registration Certificate from the National Medical Products Administration for its self-developed Septin9, SDC2, and NDRG4 gene methylation detection kits using fluorescent PCR method, which assist in diagnosing the risk of colorectal cancer in patients [1] Company Summary - The detection kit is designed for in vitro qualitative detection of the methylation status of Septin9, SDC2, and NDRG4 genes in human fecal DNA samples [1] - This development indicates a significant advancement in the company's product offerings in the medical diagnostics field, particularly in cancer risk assessment [1]